OLD Category: biofluids

Usefulness of the nCounter Analysis System to Monitor Immune-related Biomarkers in PBMCs During Anti-PD-1 Therapy

• Morisaki T et al.,

Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson’s disease

• Mollenhauer B et al.,

Longitudinal Analyses of Cerebrospinal Fluid α-Synuclein in Prodromal and Early Parkinson’s Disease

• Mollenhauer B, Caspell-Garcia CJ, Coffey CS...Chahine LM, Marek K, Galasko D

Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study

• Lou E et al.,

Metabolic perturbations and cellular stress underpin susceptibility to symptomatic live-attenuated yellow fever infection

• Chan KR et al.,

Discovery and Validation of Novel Biomarkers for Detection of Epithelial Ovarian Cancer

• Kulbe H et al.,

Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia

• Jafek JL et al.,

Faecal microRNAs as a non-invasive tool in the diagnosis of colonic adenomas and colorectal cancer: A meta-analysis

• Yau TO et al.,

Nuclear-Biased DUSP6 Expression is Associated with Cancer Spreading Including Brain Metastasis in Triple-Negative Breast Cancer

• Wu F et al.,

Variable global distribution of cell-of-origin from the ROBUST phase 3 study in diffuse large B-cell lymphoma

• Nowakowski GS et al.,

Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer

• Beck TN et al.,

Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles

• Reynolds JA et al.,